Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,838 | -5,005 | 29,290 | 63,016 | 92,105 |
| Depreciation Amortization | 152 | -654 | 125 | 585 | 386 |
| Accounts payable and accrued liabilities | -823 | -981 | 2,711 | 1,637 | 7,701 |
| Other Working Capital | -6,282 | 3,350 | 307 | -3,683 | 3,235 |
| Other Operating Activity | 1,295 | -110,371 | -118,895 | -123,085 | -134,111 |
| Operating Cash Flow | $-12,496 | $-113,661 | $-86,462 | $-61,530 | $-30,684 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -91,999 | -109,999 | -1,787 | 39,461 |
| PPE Investments | -5 | -1,285 | -1,276 | -1,270 | -1,149 |
| Net Acquisitions | N/A | 130,000 | 130,000 | 130,000 | 130,000 |
| Investing Cash Flow | $-5 | $36,716 | $18,725 | $126,943 | $168,312 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15 | 596 | 564 | 440 | 440 |
| Financing Cash Flow | $15 | $596 | $564 | $440 | $440 |
| Beginning Cash Position | 49,540 | 110,335 | 110,335 | 110,335 | 110,335 |
| End Cash Position | 37,054 | 33,986 | 43,162 | 176,188 | 248,403 |
| Net Cash Flow | $-12,486 | $-76,349 | $-67,173 | $65,853 | $138,068 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,496 | -113,661 | -86,462 | -61,530 | -30,684 |
| Capital Expenditure | -5 | -1,285 | -1,276 | -1,270 | -1,149 |
| Free Cash Flow | -12,501 | -114,946 | -87,738 | -62,800 | -31,833 |